Precigen Analyst Ratings
Precigen Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/10/2023 | 383.87% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy |
06/05/2023 | 1029.03% | JMP Securities | → $14 | Reiterates | → Market Outperform |
05/23/2023 | — | JP Morgan | Initiates Coverage On | → Neutral | |
05/11/2023 | 1029.03% | JMP Securities | → $14 | Reiterates | Market Outperform → Market Outperform |
03/07/2023 | 1029.03% | JMP Securities | → $14 | Reiterates | → Market Outperform |
03/07/2023 | 383.87% | HC Wainwright & Co. | → $6 | Reiterates | → Buy |
01/30/2023 | 706.45% | Cantor Fitzgerald | $7 → $10 | Maintains | Overweight |
11/18/2022 | 464.52% | Cantor Fitzgerald | → $7 | Initiates Coverage On | → Overweight |
11/10/2022 | 1029.03% | JMP Securities | $13 → $14 | Maintains | Market Outperform |
08/09/2022 | 383.87% | HC Wainwright & Co. | $10 → $6 | Maintains | Buy |
02/25/2021 | 948.39% | Stifel | → $13 | Initiates Coverage On | → Buy |
02/22/2021 | 1029.03% | Wells Fargo | → $14 | Initiates Coverage On | → Overweight |
12/16/2020 | 706.45% | HC Wainwright & Co. | $8 → $10 | Maintains | Buy |
05/08/2020 | 303.23% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
---|---|---|---|---|---|
08/10/2023 | 383.87% | HC Wainwright & Co. | → 6 美元 | 重申 | 购买 → 购买 |
06/05/2023 | 1029.03% | JMP 证券 | → 14 美元 | 重申 | → 市场跑赢大盘 |
05/23/2023 | — | 摩根大通 | 启动覆盖开启 | → 中立 | |
05/11/2023 | 1029.03% | JMP 证券 | → 14 美元 | 重申 | 市场跑赢大盘 → 市场跑赢大盘 |
03/07/2023 | 1029.03% | JMP 证券 | → 14 美元 | 重申 | → 市场跑赢大盘 |
03/07/2023 | 383.87% | HC Wainwright & Co. | → 6 美元 | 重申 | → 购买 |
01/30/2023 | 706.45% | 坎托·菲茨杰拉德 | 7 美元 → 10 美元 | 维护 | 超重 |
11/18/2022 | 464.52% | 坎托·菲茨杰拉德 | → 7 美元 | 启动覆盖开启 | → 超重 |
2022 年 10 月 11 日 | 1029.03% | JMP 证券 | 13 美元 → 14 美元 | 维护 | 市场表现跑赢大盘 |
08/09/2022 | 383.87% | HC Wainwright & Co. | 10 美元 → 6 美元 | 维护 | 购买 |
2021 年 2 月 25 日 | 948.39% | Stifel | → 13 美元 | 启动覆盖开启 | → 购买 |
2021 年 2 月 22 日 | 1029.03% | 富国银行 | → 14 美元 | 启动覆盖开启 | → 超重 |
2020 年 12 月 16 日 | 706.45% | HC Wainwright & Co. | 8 美元 → 10 美元 | 维护 | 购买 |
05/08/2020 | 303.23% | HC Wainwright & Co. | → 5 美元 | 启动覆盖开启 | → 购买 |
What is the target price for Precigen (PGEN)?
Precigen (PGEN) 的目标价格是多少?
The latest price target for Precigen (NASDAQ: PGEN) was reported by HC Wainwright & Co. on August 10, 2023. The analyst firm set a price target for $6.00 expecting PGEN to rise to within 12 months (a possible 383.87% upside). 9 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年8月10日公布了Precigen(纳斯达克股票代码:PGEN)的最新目标股价。这家分析公司将目标股价定为6.00美元,预计PGEN将在12个月内升至6.00美元(可能上涨383.87%)。去年有9家分析公司公布了评级。
What is the most recent analyst rating for Precigen (PGEN)?
分析师对 Precigen (PGEN) 的最新评级是多少?
The latest analyst rating for Precigen (NASDAQ: PGEN) was provided by HC Wainwright & Co., and Precigen reiterated their buy rating.
Precigen(纳斯达克股票代码:PGEN)的最新分析师评级由HC Wainwright & Co. 提供,Precigen 重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Precigen (PGEN)?
Precigen (PGEN) 的下一个分析师评级何时公布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Precigen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Precigen was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
分析师在进行了广泛的研究(包括浏览公开财务报表、与Precigen的高管和客户交谈以及听取财报电话会议)后得出了股票评级。大多数分析师每三个月进行一次评级,因此每家公司每年应该获得4个评级。Precigen的最后一次评级是在2023年8月10日提交的,因此您应该预计下一个评级将在2024年8月10日左右公布。
Is the Analyst Rating Precigen (PGEN) correct?
分析师对 Precigen (PGEN) 的评级是否正确?
While ratings are subjective and will change, the latest Precigen (PGEN) rating was a reiterated with a price target of $0.00 to $6.00. The current price Precigen (PGEN) is trading at is $1.24, which is within the analyst's predicted range.
虽然评级是主观的,会发生变化,但最新的Precigen(PGEN)评级得到了重申,目标股价为0.00美元至6.00美元。Precigen(PGEN)目前的交易价格为1.24美元,在分析师的预测区间内。
译文内容由第三方软件翻译。